GlassScriptPhysician profile
James M Howard
NPI 1841304961
$1,630.52
in general payments reported to CMS, 2019-2025
28 companies · $59.39 in 2025
The $59.39 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $49.20 · 2021: $377 · 2022: $481 · 2023: $166 · 2024: $339 · 2025: $59.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $251.54 | 2022-2025 | Erleada, Balversa, Akeega |
| Medtronic USA, INC. | $160.75 | 2019-2020 | |
| Axonics, INC. | $131.08 | 2021-2024 | Axonics, Bulkamid |
| Coloplast Corp | $96.47 | 2021-2025 | Altis |
| Olympus America INC. | $94.10 | 2019-2024 | Itind System, Hd Camera Head |
| Myriad Genetic Laboratories, INC. | $90.65 | 2021-2024 | Prolaris |
| Dornier Medtech America, INC | $80.85 | 2022 | |
| Astellas Pharma US INC | $76.46 | 2019-2022 | |
| Abbvie INC. | $73.74 | 2021-2024 | |
| Myovant Sciences INC. | $67.18 | 2021-2022 | |
| Medtronic, INC. | $65.58 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.66 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $51.10 | 2021-2022 | |
| Travere Therapeutics, INC. | $40.31 | 2021-2022 | |
| Blue Earth Diagnostics | $37.49 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $33.32 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $27.59 | 2024 | Adstiladrin |
| Rochester Medical Corporation | $22.58 | 2022 | |
| Calyxo, INC. | $22.44 | 2025 | Cvac Aspiration System |
| Heron Therapeutics, INC. | $22.23 | 2023 | Zynrelef |
| Dendreon Pharmaceuticals LLC | $21.09 | 2021 | |
| Procept Biorobotics Corporation | $19.47 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $18.72 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.88 | 2022 | |
| Foundation Medicine, INC. | $15.69 | 2023 | Foundationone Cdx |
| Antares Pharma, INC. | $14.31 | 2020 | |
| Pfizer INC. | $14.25 | 2021 | |
| Allergan, INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.